✦ LIBER ✦

The successes and limitations of preclinical studies in predicting the pharmacodynamics and safety of cell-surface-targeted biological agents in patients

✍ Scribed by Andrew G Polson; Reina N Fuji

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The tumour-targeting human L19-IL2 immun

✍ Manfred Johannsen; Gianluca Spitaleri; Giuseppe Curigliano; Jan Roigas; Steffen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 892 KB

Combinations of Three Chemotherapeutic A

✍ Paul A. Bunn Jr.; Karen Kelly 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 138 KB

PMS1 THE LONG-TERM UTILIZATION AND SAFET

✍ Chang, HC; Chen, LC; Tseng, HL; Wu, JS 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Evaluation of the safety and pharmacodyn

✍ Stead, R. B. 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 270 KB

Medical treatment of advanced non-small

✍ Meoni, Giulia; Cecere, Fabiana Letizia; Lucherini, Elisa; Di Costanzo, Francesco 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 239 KB

Preclinical studies in rats and squirrel

✍ Jung Hee Woo; Sarah H. Bour; Tony Dang; Yu-Jen Lee; Seong Kyu Park; Elissa Andre 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 456 KB